Simon Papillon‐Cavanagh

3.9k total citations
14 papers, 734 citations indexed

About

Simon Papillon‐Cavanagh is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Simon Papillon‐Cavanagh has authored 14 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Simon Papillon‐Cavanagh's work include Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Renal cell carcinoma treatment (3 papers). Simon Papillon‐Cavanagh is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Renal cell carcinoma treatment (3 papers). Simon Papillon‐Cavanagh collaborates with scholars based in United States, Canada and Sweden. Simon Papillon‐Cavanagh's co-authors include Nicolas Jay, Catharina Olsen, Benjamin Haibe‐Kains, Nehmé El-Hachem, Gianluca Bontempi, Alice M. Walsh, Radu Dobrin, Joseph D. Szustakowski, Parul Doshi and Jacek Majewski and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Simon Papillon‐Cavanagh

13 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Papillon‐Cavanagh United States 10 314 256 223 129 125 14 734
Lucheng Zhu China 16 277 0.9× 261 1.0× 229 1.0× 194 1.5× 62 0.5× 54 713
Fangmeng Fu China 15 293 0.9× 130 0.5× 211 0.9× 286 2.2× 67 0.5× 66 744
Christopher Schroeder Germany 17 249 0.8× 162 0.6× 308 1.4× 153 1.2× 43 0.3× 53 740
Mark Gustavson United States 17 393 1.3× 155 0.6× 359 1.6× 243 1.9× 56 0.4× 30 813
Laurie L. Carr United States 12 186 0.6× 244 1.0× 271 1.2× 85 0.7× 78 0.6× 15 810
Saud H. AlDubayan United States 14 348 1.1× 172 0.7× 185 0.8× 192 1.5× 123 1.0× 32 786
Eoghan Ruadh Malone Canada 5 265 0.8× 158 0.6× 203 0.9× 303 2.3× 72 0.6× 20 605
Vilppu J. Tuominen Finland 12 295 0.9× 134 0.5× 285 1.3× 164 1.3× 32 0.3× 13 816
Lei Song United States 14 466 1.5× 177 0.7× 106 0.5× 288 2.2× 119 1.0× 41 849
Kamlesh K. Yadav United States 14 412 1.3× 322 1.3× 156 0.7× 305 2.4× 47 0.4× 30 895

Countries citing papers authored by Simon Papillon‐Cavanagh

Since Specialization
Citations

This map shows the geographic impact of Simon Papillon‐Cavanagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Papillon‐Cavanagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Papillon‐Cavanagh more than expected).

Fields of papers citing papers by Simon Papillon‐Cavanagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Papillon‐Cavanagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Papillon‐Cavanagh. The network helps show where Simon Papillon‐Cavanagh may publish in the future.

Co-authorship network of co-authors of Simon Papillon‐Cavanagh

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Papillon‐Cavanagh. A scholar is included among the top collaborators of Simon Papillon‐Cavanagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Papillon‐Cavanagh. Simon Papillon‐Cavanagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Julien, Cédric, et al.. (2022). Identification of FAT3 as a new candidate gene for adolescent idiopathic scoliosis. Scientific Reports. 12(1). 12298–12298.
2.
Motzer, Robert J., Toni K. Choueiri, David F. McDermott, et al.. (2022). Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(3). e004316–e004316. 63 indexed citations
3.
Kumar, Namit, Simon Papillon‐Cavanagh, Hao Tang, et al.. (2022). A multi‐omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti‐PD1 response in solid tumors. International Journal of Cancer. 151(11). 2043–2054. 5 indexed citations
4.
Ross‐Macdonald, Petra, Alice M. Walsh, Scott D. Chasalow, et al.. (2021). Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. Journal for ImmunoTherapy of Cancer. 9(3). e001506–e001506. 28 indexed citations
5.
Papillon‐Cavanagh, Simon, Julia F. Hopkins, Shakti Ramkissoon, Lee A. Albacker, & Alice M. Walsh. (2021). Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations. SHILAP Revista de lepidopterología. 1(1). 56–56. 3 indexed citations
6.
Papillon‐Cavanagh, Simon, Parul Doshi, Radu Dobrin, Joseph D. Szustakowski, & Alice M. Walsh. (2020). STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort. ESMO Open. 5(2). e000706–e000706. 142 indexed citations
7.
Motzer, Robert J., Toni K. Choueiri, David F. McDermott, et al.. (2020). Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N+I) or sunitinib (S) in advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. 38(15_suppl). 5009–5009. 36 indexed citations
8.
9.
Fontebasso, Adam M., Tenzin Gayden, Hamid Nikbakht, et al.. (2014). Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors. Acta Neuropathologica. 128(5). 615–627. 28 indexed citations
10.
11.
Papillon‐Cavanagh, Simon, Nicolas Jay, Nehmé El-Hachem, et al.. (2013). Comparison and validation of genomic predictors for anticancer drug sensitivity. Journal of the American Medical Informatics Association. 20(4). 597–602. 45 indexed citations
12.
Jay, Nicolas, Simon Papillon‐Cavanagh, Catharina Olsen, et al.. (2013). mRMRe: an R package for parallelized mRMR ensemble feature selection. Bioinformatics. 29(18). 2365–2368. 187 indexed citations
13.
Srour, Myriam, Jeremy Schwartzentruber, Fadi F. Hamdan, et al.. (2012). Mutations in C5ORF42 Cause Joubert Syndrome in the French Canadian Population. The American Journal of Human Genetics. 90(4). 693–700. 92 indexed citations
14.
Orr, Andrew, Marie‐Pierre Dubé, Juan Carlos Zenteno, et al.. (2011). Mutations in a novel serine protease PRSS56 in families with nanophthalmos.. PubMed. 17. 1850–61. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucheng Zhu Breakdown of academic impact, for papers by Fangmeng Fu Breakdown of academic impact, for papers by Christopher Schroeder Breakdown of academic impact, for papers by Mark Gustavson Breakdown of academic impact, for papers by Laurie L. Carr Breakdown of academic impact, for papers by Saud H. AlDubayan Breakdown of academic impact, for papers by Eoghan Ruadh Malone Breakdown of academic impact, for papers by Vilppu J. Tuominen Breakdown of academic impact, for papers by Lei Song Breakdown of academic impact, for papers by Kamlesh K. Yadav
Rankless by CCL
2026